Scientists from Nanjing University recently developed a new solid-phase microextraction (SPME)-based system for detecting ...

Tubulis has dosed the first subject in the multicentre Phase I/IIa 5-STAR 1-01 trial to clinically evaluate its second drug ...

Aker Solutions' revenue rose 43% in the fourth quarter of 2024, and the company expects a solid order backlog in 2025 ...

CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in ...

Shares of solid tumor concern Zymeworks Inc. have barely budged since the company obtained its first approval. Click here to read why ZYME stock is a Hold.

Traditional solid phase extraction (SPE) revolutionized sample preparation, but it often involves high solvent consumption and complex procedures. Micro solid phase extraction (μSPE) offers a ...

Phase I comprises dose escalation to determine the safety profile and to identify the maximum tolerated dose and/or the identified dose for optimization in patients with advanced solid tumor ...

Tubulis continues expansion of its clinical pipeline with a second ADC drug candidate entering the clinic TUB-030 is a next-generation ADC targeting 5T4 with an exatecan payload, developed ...